Bankier Alain D 4
4 · Intiva BioPharma Inc. · Filed Nov 30, 2017
Insider Transaction Report
Form 4
Bankier Alain D
Director
Transactions
- Other
Class B Warrants (right to buy)
2017-11-29+28,000→ 28,000 totalExercise: $0.38From: 2017-11-29Exp: 2018-05-07→ Common Stock (28,000 underlying) - Other
Common Stock
2017-11-29+1,384,083→ 2,200,000 total - Other
Class A Warrants (right to buy)
2017-11-29+28,000→ 28,000 totalExercise: $0.25From: 2017-11-29Exp: 2018-01-31→ Common Stock (28,000 underlying) - Other
Class C Warrants (right to buy)
2017-11-29+28,000→ 28,000 totalExercise: $0.50From: 2017-11-29Exp: 2018-07-14→ Common Stock (28,000 underlying)
Footnotes (5)
- [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
- [F2]Acquired in exchange for all of Alain Bankier's shares of Intiva BioPharma Inc.
- [F3]Acquired in exchange for all of Alain Bankier's Class A warrants of Intiva BioPharma Inc.
- [F4]Acquired in exchange for all of Alain Bankier's Class B warrants of Intiva BioPharma Inc.
- [F5]Acquired in exchange for all of Alain Bankier's Class C warrants of Intiva BioPharma Inc.